Considerations for simultaneous testing of COVID-19 and tuberculosis in high-burden countries
- PMID: 35122718
- PMCID: PMC8809899
- DOI: 10.1016/S2214-109X(22)00002-X
Considerations for simultaneous testing of COVID-19 and tuberculosis in high-burden countries
Conflict of interest statement
All authors are employees of FIND. FIND received grants from the Bill & Melinda Gates Foundation and The Global Fund to Fight AIDS, Tuberculosis and Malaria for the simultaneous testing efforts from which this Comment draws the lessons learned. FIND is co-convenor of the Access to COVID-19 Tools Accelerator Diagnostics Pillar along with The Global Fund. We declare no other competing interests. Writing support was provided by Talya Underwood of Anthos Communications, UK, and was funded by FIND according to Good Publication Practice guidelines.
References
-
- The Global Fund Global Fund results report reveals COVID-19 devastating impact on HIV, TB and malaria programs. Sept 8, 2021. https://www.theglobalfund.org/en/news/2021-09-08-global-fund-results-rep...
-
- WHO Global tuberculosis report 2021. Oct 14, 2021. https://www.who.int/publications/i/item/9789240037021
-
- Sy KTL, Haw NJL, Uy J. Previous and active tuberculosis increases risk of death and prolongs recovery in patients with COVID-19. Infect Dis (Lond) 2020;52:902–907. - PubMed
-
- Western Cape Department of Health in collaboration with the National Institute for Communicable Diseases, South Africa Risk factors for coronavirus disease 2019 (COVID-19) death in a population cohort study from the Western Cape province, South Africa. Clin Infect Dis. 2021;73:e2005–e2015. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
